Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal Denervation in Heart Failure Treatment: Data for a Self-Fulfilling Prophecy.
Dimitriadis K, Iliakis P, Pyrpyris N, Tatakis F, Fragkoulis C, Mantziaris V, Plaitis A, Beneki E, Tsioufis P, Hering D, Kollias A, Konstantinidis D, Tsioufis K. Dimitriadis K, et al. Among authors: iliakis p. J Clin Med. 2024 Nov 6;13(22):6656. doi: 10.3390/jcm13226656. J Clin Med. 2024. PMID: 39597800 Free PMC article. Review.
Efficacy of Chronic Use of Sodium-Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis.
Dimitriadis K, Vakka A, Pyrpyris N, Apostolos A, Beneki E, Stathopoulou E, Giannou P, Tsioufis P, Iliakis P, Aznaouridis K, Petras D, Tsioufis K. Dimitriadis K, et al. Among authors: iliakis p. Am J Cardiovasc Drugs. 2024 Oct 11. doi: 10.1007/s40256-024-00684-y. Online ahead of print. Am J Cardiovasc Drugs. 2024. PMID: 39392560
ANOCA updated: From pathophysiology to modern clinical practice.
Dimitriadis K, Pyrpyris N, Sakalidis A, Dri E, Iliakis P, Tsioufis P, Tatakis F, Beneki E, Fragkoulis C, Aznaouridis K, Tsioufis K. Dimitriadis K, et al. Among authors: iliakis p. Cardiovasc Revasc Med. 2024 Sep 21:S1553-8389(24)00672-9. doi: 10.1016/j.carrev.2024.09.010. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 39341735 Review.
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes.
Dimitriadis K, Pyrpyris N, Iliakis P, Beneki E, Adamopoulou E, Papanikolaou A, Konstantinidis D, Fragkoulis C, Kollias A, Aznaouridis K, Tsioufis K. Dimitriadis K, et al. Among authors: iliakis p. J Clin Med. 2024 Aug 25;13(17):5040. doi: 10.3390/jcm13175040. J Clin Med. 2024. PMID: 39274253 Free PMC article. Review.
Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
Dimitriadis K, Pyrpyris N, Iliakis P, Kanatas P, Theofilis P, Sakalidis A, Apostolos A, Tsioufis P, Papanikolaou A, Aznaouridis K, Aggeli K, Tsioufis K. Dimitriadis K, et al. Among authors: iliakis p. J Cardiol. 2024 Aug 10:S0914-5087(24)00148-5. doi: 10.1016/j.jjcc.2024.08.002. Online ahead of print. J Cardiol. 2024. PMID: 39134301 Review.
35 results